The Latest Breaking News from MHRA

Pre-filled injection devices claimed to hold Ozempic or Saxenda may contain other substances, regulator says

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

Hospital admissions for life-threatening allergic reactions have increased from 12,361 in 2002-03 to 25,721 in the past year, latest NHS figures show.

Ron Huss-Smickler, 41 from Birmingham, and Steven Lawrence Beckford, 39 from Edgbaston, bought the non-certified coronavirus tests from Alibaba.

Number of people taken to hospital increased to 25,721 in 2022-23, from 12,361 two decades before

Data obtained by drugs regulator the MHRA shows there were 25,721 admissions to England’s hospitals for allergies and anaphylaxis in 2022/23.

Ozempic and Saxenda among drugs being reviewed after five reports of suspected adverse reactions in patients

Regulator acts after firm paid millions by NHS for healthcare gave patients wrong chemotherapy dose

Abusing the medical mixture has prompted a ban on UK sales